dc.contributor.author | Sneyd, John | |
dc.date.accessioned | 2017-01-23T10:08:20Z | |
dc.date.available | 2017-01-23T10:08:20Z | |
dc.date.issued | 2016-12-12 | |
dc.identifier.issn | 0007-0912 | |
dc.identifier.issn | 1471-6771 | |
dc.identifier.uri | http://hdl.handle.net/10026.1/8289 | |
dc.format.extent | 684-687 | |
dc.format.medium | Print | |
dc.language | en | |
dc.language.iso | en | |
dc.publisher | Elsevier BV | |
dc.subject | Anesthetics, Intravenous | |
dc.subject | Drug Discovery | |
dc.subject | Humans | |
dc.title | Time to move the goalposts? Do we need new targets for developing i.v. anaesthetics? | |
dc.type | journal-article | |
dc.type | Editorial | |
plymouth.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000389640900002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008 | |
plymouth.issue | 6 | |
plymouth.volume | 117 | |
plymouth.publication-status | Published | |
plymouth.journal | British Journal of Anaesthesia | |
dc.identifier.doi | 10.1093/bja/aew330 | |
plymouth.organisational-group | /Plymouth | |
plymouth.organisational-group | /Plymouth/Faculty of Health | |
plymouth.organisational-group | /Plymouth/Users by role | |
dc.publisher.place | England | |
dcterms.dateAccepted | 2016-04-01 | |
dc.rights.embargodate | 2017-12-12 | |
dc.identifier.eissn | 1471-6771 | |
dc.rights.embargoperiod | No embargo | |
rioxxterms.versionofrecord | 10.1093/bja/aew330 | |
rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/all-rights-reserved | |
rioxxterms.licenseref.startdate | 2016-12-12 | |
rioxxterms.type | Journal Article/Review | |
plymouth.oa-location | http://dx.doi.org/10.1093/bja/aew330 | |